Cite
Iqbal MS, Wilkinson D, Tin A, et al. Cetuximab in the management of nasopharyngeal carcinoma - a narrative review. J Laryngol Otol. 2019;133(10):843-855doi: 10.1017/S0022215119001853.
Iqbal, M. S., Wilkinson, D., Tin, A., Bossi, P., Gradwell-Nelson, L., Kovarik, J., O'Hara, J., & Kelly, C. (2019). Cetuximab in the management of nasopharyngeal carcinoma - a narrative review. The Journal of laryngology and otology, 133(10), 843-855. https://doi.org/10.1017/S0022215119001853
Iqbal, M S, et al. "Cetuximab in the management of nasopharyngeal carcinoma - a narrative review." The Journal of laryngology and otology vol. 133,10 (2019): 843-855. doi: https://doi.org/10.1017/S0022215119001853
Iqbal MS, Wilkinson D, Tin A, Bossi P, Gradwell-Nelson L, Kovarik J, O'Hara J, Kelly C. Cetuximab in the management of nasopharyngeal carcinoma - a narrative review. J Laryngol Otol. 2019 Oct;133(10):843-855. doi: 10.1017/S0022215119001853. Epub 2019 Sep 11. PMID: 31506113.
Copy
Download .nbib